A medical device, such as an intra-aortic balloon pump or carrier with an extendable wheel track and handle configured to be removably carried and integrated with a cart. The wheel track is configured to extend upon extension of the handle and to return to its original position upon retraction of the handle.

A dual balloon catheter having two independently inflatable balloons that provides complete or intermittent synchronous occlusion of blood vessels (such as the contralateral iliac veins, for example) via the balloons, which can be used for the purpose of decreasing the pressure in the inferior vena cava, which results in decongestion of the kidneys, liver/splanchnic compartment, lymphatic system, and the heart.

An intravascular device for pumping blood includes a catheter comprising a membrane chamber located between a proximal end and a distal end of the catheter. An inflatable membrane is disposed within the membrane chamber. The intravascular device includes a first one-way valve and optionally a second one-way valve configured to permit blood flow in a first direction. The first one-way valve may be positioned proximal to the membrane chamber, and the second one-way valve may be positioned distal to the membrane chamber. Methods related to intravascular devices and their respective use are provided.

A device (2) for providing circulatory assistance is provided and comprises a balloon (4) comprising a membrane defining a cavity having an internal volume (Vc), wherein the balloon comprises a proximal portion (4a) comprising a proximal end and a distal portion (4b) comprising a distal end. The device (2) further comprises a first catheter, affixed to the distal end of the balloon (4) at a first fixation point (P1) and a second catheter (8), affixed to the proximal end of the balloon at a second fixation point (P2). The second catheter (8) is configured for axial movement with respect to the first catheter or guide wire (6) between a first position in which the first and second fixation points (P1, P2) are spaced apart from each other in the longitudinal direction by a first distance (Dx), which is variable to bring about inversion of the balloon.

According to an aspect, an implantable device includes a pressurize fluid reservoir configured to hold fluid, an inflatable member; and an electronic pump assembly. The electronic pump assembly includes a pump, an active valve, a pressure sensor configured to monitor a pressure of the inflatable member, and a controller configured to cause the active valve to be in an open position during at least a portion of an inflation cycle to allow the fluid to be transferred from the pressurized fluid reservoir to the inflatable member. The controller is configured to transition the active valve to a closed position in response to the pressure of the inflatable member achieving a target pressure.

A device for reducing pulsatile pressure within a vessel to treat heart disease, such as pulmonary hypertension, includes a compliant body structured to expand and contract upon changes in pressure within the vessel, a reservoir structured for holding a fluid therein, and a conduit extending between and fluidly coupling the reservoir and the compliant body, wherein the device includes a graphene-polymer composite designed to resist diffusion of the fluid through the device.

Some embodiments of percutaneous ventricular assist devices have a two-part design that includes a housing component and a separately deployable rotatable inner catheter component. The housing component can include an expandable pump housing. The inner catheter can include an expandable pump impeller and an associated flexible drive shaft. The drive shaft can be coupled to a motor located external to the patient. The motor can rotate the drive shaft to spin the pump impeller inside of the pump housing, causing blood to be pumped within the patient. In some embodiments, the pump impeller is inflatable or self-expandable. The two-part percutaneous ventricular assist devices with inflatable or self-expandable pump impellers are designed to have very small delivery profiles. Accordingly, various deployment modalities, including radial artery deployment, are practicable using the two-part percutaneous ventricular assist devices described herein.

A cardiac assist device (1) with a cup element (2), an inner balloon element (5) and a tube element (6). The cup element (2) has a cup wall (2a), one or more in-flow openings (3), and an outflow element (4 having an aperture (4a). The inner balloon element (5) is positioned inside the cup element (2) free from the outflow element (4). The tube element (6) is arranged for inflating and deflating the inner balloon element (5) during operation. During operation in a pumping operational mode, the combination of first material, dimensions of the cup wall (2a), and dimensions of the outflow element (4) provides a containment force by the cup element (2) counteracting an outward directed force of the inner balloon element (5).

A cardiac assist device (1) with a cup element (2), an inner balloon element (5) and a tube element (6). The cup element (2) has a cup wall (2a), one or more in-flow openings (3), and an outflow element (4 having an aperture (4a). The inner balloon element (5) is positioned inside the cup element (2) free from the outflow element (4). The tube element (6) is arranged for inflating and deflating the inner balloon element (5) during operation. During operation in a pumping operational mode, the combination of first material, dimensions of the cup wall (2a), and dimensions of the outflow element (4) provides a containment force by the cup element (2) counteracting an outward directed force of the inner balloon element (5).

In a method for intermittently occluding the coronary sinus, in which the coronary sinus is occluded using an occlusion device, the fluid pressure in the occluded coronary sinus is continuously measured and stored, the fluid pressure curve is determined as a function of time, and the occlusion of the coronary sinus is triggered and/or released as a function of at least one characteristic value derived from the measured pressure values. The pressure increase and/or pressure decrease per time unit each occurring at a heart beat are used as characteristic values.